So-- we have a management team that came into a DEAD company. Not operating. Shares held by many that had long mentally written off.
Did the new team do what so many GREEDY teams do in this type scenario? Reverse split the stock big time so the long suffering old shareholders ended up with only 10% of the new share structure? Then gift themselves the other 90%, not from what I am reading in the filings.
No, they started building the company, without pay, executing license agreements, recruiting biotech expertise, raised capital, filed years of financials and then converted. Sure, they had some shares initially, but they did not overwhelm the market early on until they showed some proof of their business plan and their growing Scientific Advisory Board and Management team.
The recent conversion is in restricted stock--until May 2022. Then, like trader noted, they are restricted in selling to 1% of the current shares outstanding every 90 day period.
I am not buying up these cheap shares down here because I think I will own all these shares one year from now.
Buying at .08 and 092 and .101 and .11 recently because I think I will see a minimum of a 200% gain within six months.
The CUBT CEO has indicated that the company should be initiating clinical trials by the end of the year. Even if it is he first quarter of next year, I do not believe CUBT will be below .30.
JMO, but the fact that this company is NOT doing BS pumping is why they attracting accomplished scientists to the SAB and getting licenses from the NIH etc.
Do you think that potential partners and pending SAB members ignore the public company info?
I bet there are already interested parties on their investor database to see what is coming out from the company. Does the CEO pump the stock?
Does the CEO publicly alert shareholders to a conversion? (Sorry, that is the most ridiculous suggestion I have seen so far.)
JMO
